UK's Smith+Nephew cuts annual revenue expectations

Impact · against what's priced in

Smith+Nephew is likely to face downward price pressure following a formal reduction in full-year revenue growth guidance. The catalyst is driven by persistent weakness in the U.S. orthopaedics market, the company's largest segment.

SNN−0.60

No priced-in read yet

In context

The company has lowered its full-year revenue growth forecast due to continued weakness in its U.S. orthopaedics unit.

Read from the article alone

Actual

• healthcare
• SNN
• forecast cut
• medical devices
• orthopaedics
• revenue guidance
• us market

Search tags